Recognizing and treating myocarditis in recent-onset systemic sclerosis heart disease: potential utility of immunosuppressive therapy in cardiac damage progression

Filippo Crea, Maurizio Pieroni, Costantino Smaldone, Mara Campioni, Fulvio Bellocci, Lorenzo Bonomo, Gianfranco Ferraccioli

Research output: Contribution to journalArticlepeer-review

81 Citations (Scopus)

Abstract

Scleroderma heart disease is a major risk of death in systemic sclerosis (SSc). Mechanisms underlying myocardial damage are still unclear. We performed an extensive study of SSc patients with recent-onset symptoms for heart disease and examined the efficacy of immunosuppressive therapy.
Original languageEnglish
Pages (from-to)526-535
Number of pages10
JournalSEMINARS IN ARTHRITIS AND RHEUMATISM
Volume43
DOIs
Publication statusPublished - 2014

Keywords

  • ANCA
  • Adult
  • Aged
  • Disease Progression
  • Female
  • Heart disease
  • Humans
  • Immunosuppressive Agents
  • Male
  • Middle Aged
  • Myocarditis
  • Parvovirus B19
  • Scleroderma, Systemic
  • Systemic sclerosis
  • Treatment
  • Treatment Outcome

Fingerprint Dive into the research topics of 'Recognizing and treating myocarditis in recent-onset systemic sclerosis heart disease: potential utility of immunosuppressive therapy in cardiac damage progression'. Together they form a unique fingerprint.

Cite this